BipD-Mediated Hijacking of Host E3 Ligase Drives Mitophagy in Infection

Study Background and Research Question

Mitochondria play a central role in cellular quality control, particularly through mitophagy, the selective autophagic removal of damaged mitochondria. Proper regulation of this process is essential for maintaining mitochondrial function and limiting excessive reactive oxygen species (ROS), especially during infection. Over recent years, various pathogens have been shown to manipulate mitophagy to enhance their intracellular survival, but the precise molecular strategies used by many bacterial species remain incompletely defined. Burkholderia pseudomallei, the causative agent of melioidosis, is a facultative intracellular pathogen capable of evading host immunity and persisting within host cells. This study addresses how B. pseudomallei manipulates host mitophagy for its survival, focusing on the role of its type III secretion system protein BipD (reference).

Key Innovation from the Reference Study

The central innovation of this research is the discovery that the BipD protein of B. pseudomallei directly interacts with the host BTB-domain proteins KLHL9 and KLHL13, recruiting the cullin-RING ligase CUL3 E3 complex. This hijacked complex mediates K63-linked ubiquitination of the inner mitochondrial membrane protein IMMT, thereby triggering mitophagy in host cells. This pathway is distinct from canonical Parkin-dependent mitophagy and introduces a previously unrecognized strategy by which bacterial pathogens can subvert host mitochondrial quality control to promote their own intracellular persistence (reference).

Methods and Experimental Design Insights

The authors used a combination of proteomics, molecular interaction mapping, and functional cell biology assays to dissect the mechanism of host mitophagy manipulation. Key methodological highlights include:

• Protein–protein interaction screening: Co-immunoprecipitation and mass spectrometry were employed to identify host proteins interacting with BipD, focusing on KLHL9, KLHL13, and CUL3.
• Ubiquitome profiling: Ubiquitinated substrates in infected mouse macrophages were mapped, leading to the identification of IMMT as a target of the hijacked E3 ligase complex.
• Genetic manipulations: CRISPR/Cas9-mediated knockout and rescue experiments clarified the necessity of specific lysine residues (K211) on IMMT for K63-linked ubiquitination and mitophagy induction.
• Functional readouts: Mitophagy was monitored by LC3 co-localization assays, mitochondrial ROS quantification, and cell survival measurements under infection conditions.

Protocol Parameters

• assay | Co-immunoprecipitation | 1–2 mg total protein per sample | Required for mapping BipD–host protein interactions | Literature-backed | (reference)
• assay | Ubiquitome profiling (MS) | 10⁷ macrophages per sample | For comprehensive mapping of ubiquitinated proteins post-infection | Literature-backed | (reference)
• assay | CRISPR/Cas9 knockout | Multiplicity of infection (MOI) 10 for B. pseudomallei | To study gene function in infection context | Literature-backed | (reference)
• assay | Mitophagy quantification (LC3 co-localization) | Standard immunofluorescence protocols | To assess the rate of mitophagy in infected cells | Literature-backed | (reference)
• assay | Use of neddylation pathway inhibitors (e.g., MLN4924) | 0.1–1 μM in DMSO | To probe the role of neddylation/CRL activity in mitophagy | workflow_recommendation

Core Findings and Why They Matter

The study demonstrates that BipD, a type III secretion system needle tip protein, can bind both KLHL9 and KLHL13 via their BACK and Kelch domains. This interaction recruits the NEDD8 family CUL3 E3 ligase to mitochondria, a crucial step for subsequent ubiquitination events. Through ubiquitome profiling, the authors identify IMMT (inner mitochondrial membrane protein) as a direct substrate, and show that K63-linked ubiquitination at residue K211 is essential for mitophagy initiation. Notably, this pathway operates independently of canonical Parkin and provides a direct molecular link between bacterial effector proteins and host mitochondrial quality control machinery (reference).

Functionally, activation of mitophagy by this mechanism leads to lower mitochondrial ROS and promotes bacterial survival within host macrophages. Disrupting the BipD–KLHL9/KLHL13/CUL3–IMMT axis impairs mitophagy, increases ROS, and reduces intracellular persistence of B. pseudomallei, highlighting the importance of this pathway for pathogen evasion.

Comparison with Existing Internal Articles

While internal resources such as the articles on MLN4924 focus primarily on neddylation pathway inhibition in cancer models—exploring topics like cullin-RING ligase (CRL) ubiquitination inhibition and cell cycle regulation (internal, internal)—the present study extends the relevance of CRL biology into host-pathogen interactions. For example, MLN4924’s established use in dissecting CRL3-SPOP-mediated pathways (internal) is conceptually linked to the role of CUL3 E3 ligase in mitophagy revealed here. However, unlike previous cancer-centric studies, this paper connects neddylation-dependent ubiquitination to bacterial immune evasion, offering a cross-disciplinary perspective.

Limitations and Transferability

Several limitations should be considered. First, most experiments were performed in mouse macrophage models; translation to human cells and in vivo infection models will be critical for confirming the broader relevance of these findings. Second, although the role of CUL3 and IMMT is convincingly established, the potential for functional redundancy within the BTB-Kelch protein family or other E3 ligases was not exhaustively explored. Lastly, therapeutic modulation of this pathway (e.g., using NEDD8-activating enzyme inhibitors) remains to be validated in infection settings, as most chemical biology tools to date have been optimized for oncology or cell cycle studies (internal).

Why this cross-domain matters, maturity, and limitations

The intersection of neddylation pathway inhibition, traditionally a focus in cancer biology research, with anti-infective host defense strategies represents a promising but still nascent research direction. While tools such as MLN4924 have set benchmarks for the selective inhibition of NEDD8-activating enzyme in tumor models, their application in infectious disease or immunology contexts requires further validation and optimization (internal). Limitations remain regarding off-target effects and the need for infection-appropriate dosing regimens.

Research Support Resources

For researchers interested in experimentally probing the role of neddylation and cullin-RING ligase activity in host-pathogen interactions or mitophagy, selective NEDD8-activating enzyme inhibitors such as MLN4924 (SKU B1036, APExBIO) can be incorporated into relevant cellular assays. MLN4924 exhibits potent and selective inhibition of NAE activity (IC₅₀ 4 nM; product_spec) and has proven utility in modulating CRL-dependent ubiquitination, with established solubility in DMSO for in vitro workflows. While its primary application has been in cancer biology research, MLN4924 may serve as a valuable tool for dissecting neddylation-mediated processes in infection models, subject to appropriate optimization and experimental controls. For additional mechanistic guidance and troubleshooting strategies, see internal articles on MLN4924’s use in neddylation pathway studies (internal).